Company · CIK 1994702
Kyverna Therapeutics, Inc.
| CIK | 1994702 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | KYTX (Nasdaq) |
| First annual or quarterly report | 2024-03-26 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294645 | 2026-03-26 | 2026-04-02 | 3 | |
| 333-286180 | 2025-03-27 | 2025-12-18 | 5 | |
| 333-276523 | 2024-01-16 | 2024-02-08 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-02 | EFFECTDeclared effective | 333-294645 | 9999999995-26-001072 |
| 2026-04-02 | 424B5Shelf takedown | 333-294645 | 0001193125-26-140377 |
| 2026-03-26 | S-3Shelf registered | 333-294645 | 0001193125-26-126321 |
| 2025-12-18 | 424B5Shelf takedown | 333-286180 | 0001213900-25-123032 |
| 2025-12-15 | 424B5Shelf takedown | 333-286180 | 0001213900-25-121773 |
| 2025-04-15 | EFFECTDeclared effective | 333-286180 | 9999999995-25-001121 |
| 2025-04-15 | 424B5Shelf takedown | 333-286180 | 0000950170-25-054293 |
| 2025-03-27 | S-3Shelf registered | 333-286180 | 0000950170-25-046162 |
| 2024-02-08 | 424B4Final prospectus | 333-276523 | 0001193125-24-028334 |
| 2024-02-07 | EFFECTDeclared effective | 333-276523 | 9999999995-24-000343 |
| 2024-02-06 | S-1/AAmendment | 333-276523 | 0001193125-24-024683 |
| 2024-02-01 | S-1/AAmendment | 333-276523 | 0001193125-24-021237 |
| 2024-01-16 | S-1Registration filed | 333-276523 | 0001193125-24-008614 |
| 2023-10-05 | DRSDraft made public | 377-06910 | 0000950123-23-008697 |